# C_2021365EN.01001101.xml

| 10.9.2021 | EN | Official Journal of the European Union | C 365/11 |
| --- | --- | --- | --- |

10.9.2021

EN

Official Journal of the European Union

C 365/11

---

Prior notification of a concentration

(Case M.10469 — GS/Charlesbank/MDVIP)

Candidate case for simplified procedure

(Text with EEA relevance)

(2021/C 365/07)

1.

This notification concerns the following undertakings:

| — | Goldman Sachs Group, Inc. (‘GS’, United States), |
| --- | --- |

—

Goldman Sachs Group, Inc. (‘GS’, United States),

| — | Charlesbank Capital Partners, LLC (‘Charlesbank’, United States), |
| --- | --- |

—

Charlesbank Capital Partners, LLC (‘Charlesbank’, United States),

| — | MDVIP, Inc. (‘MDVIP’, United States). |
| --- | --- |

—

MDVIP, Inc. (‘MDVIP’, United States).

GS and Charlesbank acquire within the meaning of Article 3(1)(b) of the Merger Regulation joint control of the whole of MDVIP.

The concentration is accomplished by way of purchase of shares.

2.

| — | for GS: a global investment banking, securities and investment management firm that provides a range of services worldwide to corporations, financial institutions, governments and high-net-worth individuals. GS’ global activities are generally divided into four segments: (i) global markets/fixed income, currencies, and commodities, (ii) investment banking, (iii) asset management, and (iv) consumer and wealth management, |
| --- | --- |

—

for GS: a global investment banking, securities and investment management firm that provides a range of services worldwide to corporations, financial institutions, governments and high-net-worth individuals. GS’ global activities are generally divided into four segments: (i) global markets/fixed income, currencies, and commodities, (ii) investment banking, (iii) asset management, and (iv) consumer and wealth management,

| — | for Charlesbank: a private equity firm with portfolio companies active in business services, consumer, healthcare, industrial, technology and technology infrastructure, primarily in North America, |
| --- | --- |

—

for Charlesbank: a private equity firm with portfolio companies active in business services, consumer, healthcare, industrial, technology and technology infrastructure, primarily in North America,

| — | for MDVIP: operation of a network of physicians in the US who provide membership based primary care services to patients, focusing on delivering personalised medicine, patient-centered and preventive care. |
| --- | --- |

—

for MDVIP: operation of a network of physicians in the US who provide membership based primary care services to patients, focusing on delivering personalised medicine, patient-centered and preventive care.

3.

Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under the Council Regulation (EC) No 139/2004 (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.

4.

Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified:

M.10469 — GS/Charlesbank/MDVIP

Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below:

Email: COMP-MERGER-REGISTRY@ec.europa.eu

Fax +32 22964301

Postal address:

| European Commission |
| --- |
| Directorate-General for Competition |
| Merger Registry |
| 1049 Bruxelles/Brussel |
| BELGIQUE/BELGIË |

European Commission

Directorate-General for Competition

Merger Registry

1049 Bruxelles/Brussel

BELGIQUE/BELGIË

---

(1)  OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).

1

(2)  OJ C 366, 14.12.2013, p. 5.

2

---